- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 263/46 - Atomes de soufre
Détention brevets de la classe C07D 263/46
Brevets de cette classe: 74
Historique des publications depuis 10 ans
3
|
3
|
7
|
11
|
9
|
8
|
4
|
9
|
2
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Novartis AG | 11254 |
10 |
North Carolina State University | 1531 |
6 |
Gwangju Institute of Science and Technology | 738 |
3 |
Industry-Academic Cooperation Foundation, Yonsei University | 2384 |
3 |
The Institute of Cancer Research: Royal Cancer Hospital | 184 |
3 |
IFM Tre, Inc. | 5 |
3 |
Merck Sharp & Dohme LLC | 3748 |
3 |
The General Hospital Corporation | 4655 |
2 |
Takeda Pharmaceutical Company Limited | 2945 |
2 |
Kyungpook National University Industry-Academic Cooperation Foundation | 1109 |
2 |
Regeneron Pharmaceuticals, Inc. | 4019 |
2 |
The Regents of the University of Colorado, a body corporate | 2538 |
2 |
Trustees of Dartmouth College | 1065 |
2 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3053 |
2 |
Seoul National University R&db Foundation | 3335 |
2 |
PI Industries Ltd | 159 |
2 |
Novartis Inflammasome Research, Inc. | 10 |
2 |
Projini Agchem Ltd | 5 |
2 |
Merck Sharp & Dohme Corp. | 2216 |
1 |
Bayer Cropscience AG | 2136 |
1 |
Autres propriétaires | 19 |